Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$23.32 CAD
Change Today 0.00 / 0.00%
Volume 670.1K
PJC/A On Other Exchanges
Symbol
Exchange
OTC US
Toronto
Frankfurt
As of 4:27 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

jean coutu group inc-class a (PJC/A) Snapshot

Open
C$23.25
Previous Close
C$23.32
Day High
C$23.38
Day Low
C$23.25
52 Week High
01/5/15 - C$28.95
52 Week Low
07/25/14 - C$21.06
Market Cap
4.4B
Average Volume 10 Days
475.8K
EPS TTM
C$1.17
Shares Outstanding
83.6M
EX-Date
05/13/15
P/E TM
19.9x
Dividend
C$0.44
Dividend Yield
1.76%
Current Stock Chart for JEAN COUTU GROUP INC-CLASS A (PJC/A)

Related News

No related news articles were found.

jean coutu group inc-class a (PJC/A) Related Businessweek News

No Related Businessweek News Found

jean coutu group inc-class a (PJC/A) Details

The Jean Coutu Group (PJC) Inc., together with its subsidiaries, engages in the retail of pharmaceutical, parapharmaceutical, and other products in Canada. It operates through two segments, franchising and generic drugs. The company operates franchised drugstores under the PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Santé, and PJC Jean Coutu Santé Beauté names. As of February 28, 2015, it operated a network of 416 franchised stores in the provinces of Québec, New Brunswick, and Ontario. The company also operates two distribution centers and provides services to franchised stores. In addition, the company, through its subsidiary, Pro Doc Ltd, manufactures and sells generic drugs to wholesalers and pharmacists. Further, it leases and rents lands and buildings. The Jean Coutu Group (PJC) Inc. was founded in 1969 and is headquartered in Longueuil, Canada.

1,140 Employees
Last Reported Date: 04/29/15
Founded in 1969

jean coutu group inc-class a (PJC/A) Top Compensated Officers

Chief Executive Officer, President and Non-In...
Total Annual Compensation: C$939.9K
Executive Vice President of Finance and Corpo...
Total Annual Compensation: C$457.4K
President of Pro-Doc Ltée
Total Annual Compensation: C$398.9K
Executive Vice President of Network Operation...
Total Annual Compensation: C$398.9K
Executive Vice President of Pharmacy & Govern...
Total Annual Compensation: C$361.8K
Compensation as of Fiscal Year 2015.

jean coutu group inc-class a (PJC/A) Key Developments

The Jean Coutu Group (PJC) Inc. Declares Quarterly Dividend, Payable on May 29, 2015; Reports Unaudited Consolidated Financial Results for the Fourth Quarter and Fiscal Year Ended February 28, 2015; Provides Capital Expenditures Guidance for the Fiscal Year 2016; to Open 12 Stores; to Relocate 3 Stores

The board of The Jean Coutu Group (PJC) Inc. declared a quarterly dividend of $0.11 per share, an increase of 10%. This dividend will be paid on May 29, 2015, to all holders of Class A Subordinate Voting Shares and holders of Class B Shares listed in the corporation's shareholder ledger as at May 15, 2015. The company reported unaudited consolidated financial results for the fourth quarter and fiscal year ended February 28, 2015. For the quarter, the company reported revenues of $713.9 million compared with $685.4 million for the quarter ended March 1, 2014. OIBA decreased by $3.4 million to $84.1 million during the quarter ended February 28, 2015 compared with $87.5 million for the quarter ended March 1, 2014. Despite a solid operational performance, this decrease is due to the negotiation of a retroactive credit for previous quarters of $4.9 million for publicity costs recorded as a reduction of the general and operating expenses during the fourth quarter of fiscal year 2014. Net profit amounted to $55.2 million or $0.30 per diluted share compared with $57.7 million or $0.30 per diluted share for the quarter ended March 1, 2014. Operating income was $76.1 million against $79.1 million a year ago. Profit before income taxes was $75.9 million against $79.1 million a year ago. Cash flow related to operating activities was $79.7 million against $87.3 million a year ago. Purchase of property and equipment was $31.3 million against $7.3 million a year ago. For the year, the company’s revenues amounted to $2,813.6 million compared with $2,733.3 million for previous fiscal year, an increase of 2.9%. This increase is attributable to the overall market growth and the expansion of the PJC network of franchised stores despite the deflationary impact on revenues of the volume increase in prescriptions of generic drugs compared with brand name drugs as well as the price reductions of generic drugs. OIBA decreased by $2.6 million amounting to $331.9 million compared with $334.5 million for fiscal year 2014. This decrease is mainly due to the negotiation of a retroactive credit for previous fiscal years of $4.5 million for publicity costs recorded as a reduction of the general and operating expenses during fiscal year 2014. OIBA, for fiscal year 2015 was also negatively impacted by a $6.5 million expense for share-based payments instruments (stock appreciation rights and deferred share units), compared with $4.1 million for fiscal year 2014. Net profit amounted to $218.9 million or $1.17 per diluted share compared with $437.0 million or $2.12 per diluted share for fiscal year 2014. The decrease in net profit is mainly attributable to the gains of $212.7 million related to the investment in Rite Aid recognized during fiscal year 2014. Operating income was $299.9 million against $302.0 million a year ago. Profit before income taxes was $300.5 million against $516.5 million a year ago. Cash flow related to operating activities was $277.5 million against $284.4 million a year ago. Purchase of property and equipment was $79.1 million against $31.8 million a year ago. In fiscal year 2016, the company plans to allocate approximately $130.4 million to capital expenditures and to banner developments costs including $103.4 million for the new distribution center and head office. As previously announced, this project which represents a total investment of approximately $190.0 million should be completed in fiscal year 2016. The company plans to open 12 stores including 3 relocations, complete 24 store renovation and expansion projects, resulting in an expected total selling square footage of the network of 3,283,000 square feet at the end of fiscal year 2016.

The Jean Coutu Group (PJC) Inc., Q4 2015 Earnings Call, Apr 29, 2015

The Jean Coutu Group (PJC) Inc., Q4 2015 Earnings Call, Apr 29, 2015

The Jean Coutu Group (PJC) Inc. to Report Q4, 2015 Results on Apr 29, 2015

The Jean Coutu Group (PJC) Inc. announced that they will report Q4, 2015 results at 9:00 AM, US Eastern Standard Time on Apr 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PJC/A:CN C$23.32 CAD 0.00

PJC/A Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CVS Health Corp $102.38 USD -0.81
Rite Aid Corp $8.72 USD +0.02
Walgreens Boots Alliance Inc $85.84 USD -0.21
View Industry Companies
 

Industry Analysis

PJC/A

Industry Average

Valuation PJC/A Industry Range
Price/Earnings 20.1x
Price/Sales 1.6x
Price/Book 4.3x
Price/Cash Flow 17.5x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JEAN COUTU GROUP INC-CLASS A, please visit www.jeancoutu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.